YU170189A - Process for obtaining /(diarylmetoxy)alkyl/-1 pyrolidine and piperidine - Google Patents

Process for obtaining /(diarylmetoxy)alkyl/-1 pyrolidine and piperidine

Info

Publication number
YU170189A
YU170189A YU01701/89A YU170189A YU170189A YU 170189 A YU170189 A YU 170189A YU 01701/89 A YU01701/89 A YU 01701/89A YU 170189 A YU170189 A YU 170189A YU 170189 A YU170189 A YU 170189A
Authority
YU
Yugoslavia
Prior art keywords
diarylmetoxy
pyrolidine
piperidine
alkyl
obtaining
Prior art date
Application number
YU01701/89A
Other languages
English (en)
Inventor
G Ferrano
J Baranton
J C Depin
G Chavernac
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of YU170189A publication Critical patent/YU170189A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • HELECTRICITY
    • H03ELECTRONIC CIRCUITRY
    • H03HIMPEDANCE NETWORKS, e.g. RESONANT CIRCUITS; RESONATORS
    • H03H7/00Multiple-port networks comprising only passive electrical elements as network components
    • H03H7/01Frequency selective two-port networks
    • H03H7/09Filters comprising mutual inductance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
YU01701/89A 1988-09-23 1989-09-06 Process for obtaining /(diarylmetoxy)alkyl/-1 pyrolidine and piperidine YU170189A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8812430A FR2636946B1 (fr) 1988-09-23 1988-09-23 ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant

Publications (1)

Publication Number Publication Date
YU170189A true YU170189A (en) 1991-02-28

Family

ID=9370298

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01701/89A YU170189A (en) 1988-09-23 1989-09-06 Process for obtaining /(diarylmetoxy)alkyl/-1 pyrolidine and piperidine

Country Status (25)

Country Link
US (1) US4957927A (de)
EP (1) EP0360685B1 (de)
JP (1) JPH02121964A (de)
AR (1) AR246255A1 (de)
AT (1) ATE101132T1 (de)
AU (1) AU617530B2 (de)
CA (1) CA1327364C (de)
CZ (1) CZ279282B6 (de)
DD (1) DD284875A5 (de)
DE (1) DE68912860T2 (de)
DK (1) DK468389A (de)
ES (1) ES2062071T3 (de)
FR (1) FR2636946B1 (de)
HU (1) HU208422B (de)
IE (1) IE63648B1 (de)
IL (1) IL91689A0 (de)
MA (1) MA21631A1 (de)
NO (1) NO893764L (de)
NZ (1) NZ230744A (de)
OA (1) OA09135A (de)
PT (1) PT91783B (de)
SU (1) SU1757462A3 (de)
TN (1) TNSN89103A1 (de)
YU (1) YU170189A (de)
ZA (1) ZA897212B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912760A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
IE912759A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
ZA911813B (en) * 1990-08-09 1991-12-24 Sankyo Co (benzhydryloxyethylpiperidyl)aliphatic acid derivatives and their use in the treatment of allergies and asthma
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
US5578639A (en) * 1994-07-01 1996-11-26 Warner-Lambert Company PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5747523A (en) * 1996-01-24 1998-05-05 Guilford Pharmaceuticals Inc. Substituted ethyl α,α-diarylmethyl ether derivatives
US6011035A (en) * 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
ATE269848T1 (de) * 1999-04-07 2004-07-15 Univ Virginia Calciumkanalblocker als antikrebsmittel
US6946475B1 (en) 1999-04-07 2005-09-20 University Of Virginia Patent Foundation Anticancer calcium channel blockers
AU2002318185A1 (en) * 2001-06-13 2002-12-23 Teva Pharmaceutical Industries Ltd. Process for the preparation of paroxetine substantially free of alkoxy impurities
MX360640B (es) 2010-03-01 2018-11-09 Tau Therapeutics Llc Star Diagnosis e imagenologia de cancer.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives

Also Published As

Publication number Publication date
DE68912860D1 (de) 1994-03-17
NO893764L (no) 1990-03-26
IL91689A0 (en) 1990-06-10
IE63648B1 (en) 1995-05-31
DE68912860T2 (de) 1994-08-11
CA1327364C (fr) 1994-03-01
ATE101132T1 (de) 1994-02-15
EP0360685B1 (de) 1994-02-02
FR2636946A1 (fr) 1990-03-30
AR246255A1 (es) 1994-07-29
ES2062071T3 (es) 1994-12-16
DK468389D0 (da) 1989-09-22
US4957927A (en) 1990-09-18
EP0360685A1 (de) 1990-03-28
CZ540989A3 (en) 1994-11-16
IE893050L (en) 1990-03-23
AU617530B2 (en) 1991-11-28
JPH02121964A (ja) 1990-05-09
NZ230744A (en) 1991-06-25
MA21631A1 (fr) 1990-04-01
DK468389A (da) 1990-03-24
CZ279282B6 (cs) 1995-04-12
OA09135A (fr) 1991-10-31
AU4169089A (en) 1990-03-29
ZA897212B (en) 1991-03-27
FR2636946B1 (fr) 1990-11-02
PT91783B (pt) 1995-08-09
TNSN89103A1 (fr) 1991-02-04
SU1757462A3 (ru) 1992-08-23
HUT52049A (en) 1990-06-28
NO893764D0 (no) 1989-09-22
DD284875A5 (de) 1990-11-28
HU208422B (en) 1993-10-28
PT91783A (pt) 1990-03-30

Similar Documents

Publication Publication Date Title
EP0394187A3 (en) Method for the recovery of nlg
GB2198675B (en) Method of forming articles
PT85628A (en) Process for preparing piperidine derivatives
HUT40431A (en) Process for preparing piperidine derivatives
PT86427A (en) Process for preparing piperidine derivatives
YU170189A (en) Process for obtaining /(diarylmetoxy)alkyl/-1 pyrolidine and piperidine
HU896499D0 (en) Process for the preparation of piperidine derivatives
YU201987A (en) Process for obtaining dihydropyridine
ZA9010394B (en) Piperidine derivatives
HU904076D0 (en) Process for producing piperidine derivatives
YU34189A (en) Process for obtaining antihipercholesterole tetrazolic compounds and their intermediers
EP0416352A3 (en) Method of making shrinkable articles
YU7189A (en) Process for obtaining 1-alkyl-5-nitroimidazole
YU85489A (en) Process for obtaining l-alanyn
PL286613A1 (en) Method of obraining novel aminopropanel derivatives
GB2237805B (en) Method of extraction
YU122690A (en) Acaricidic compounds and process for obtaining thereof
GB2198782B (en) Packs for articles and method of producing same
YU51790A (en) Triazinic derivative and process for obtaining
EP0410322A3 (en) Method of development
HU896335D0 (en) Process for the preparation of tetrahydropyridine derivatives
GB2196566B (en) Method of forming articles
GB2230556B (en) Packs for articles and method of producing same
YU36489A (en) Process for obtaining polyestheralcohole
ZA917189B (en) Process for preparation of fluoromethyl-substituted piperidine carbodithioates